Memorial Sloan Kettering Cancer Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Memorial Sloan Kettering Cancer Center sits in the top decile of US sponsors by registered trial count (#6 of 15,751 sponsors by registered trial count).
Memorial Sloan Kettering Cancer Center: 1,884 sponsored US clinical trials, 327 recruiting.
Memorial Sloan Kettering Cancer Center sponsors 1,884 registered US clinical trials on ClinicalTrials.gov, 327 of them currently recruiting, and 1,104 completed. 75 of these trials are in Phase 3-4 (later-stage) and 1,101 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 98 trials.
Top-decile sponsor footprint
Memorial Sloan Kettering Cancer Center ranks in the top decile of sponsors by registered trial count (#6 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,884 total, page 17 of 38
Treatment of Tumors in the Urinary Collecting System of the Kidney or Ureter Using a Light Activated Drug (WST11)
NCT03617003
Donor Stem Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched Donors
NCT03615105
TCR Alpha Beta T-cell and CD19 B-cell Depleted Peripheral Blood Stem Cell Transplantation Using the CliniMACS System for Patients With Non-Malignant Hematologic Disorders From Matched or Mismatched, Related or Unrelated Donors
NCT03615144
A Study of Olaparib and Low Dose Radiotherapy for Small Cell Lung Cancer
NCT03532880
A Study of Rucaparib Administered With Radiation in Patients With Triple Negative Breast Cancer With an Incomplete Response Following Chemotherapy
NCT03542175
A Study of the Effect of Blood Stem Cell Transplant After Chemotherapy Alone in Patients With Fanconi Anemia
NCT03600909
Geriatric Communication Skills Training Program for Oncology Clinicians
NCT03530969
Short Course Daratumumab in Patients With Multiple Myeloma
NCT03490344
Study of Palliative Radiation Therapy vs. no Palliative Radiation Therapy for Patients With High Risk Bone Metastases That Are Not Causing Significant Pain
NCT03523351
Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma
NCT03524326
Study of Proton Radiation to the Brain and Spinal Cord for Patients With Leptomeningeal Metastases
NCT03520504
Pilot Trial of the Robotic Uterine Manipulator
NCT03517228
Early Staged Consent Before Prostate Biopsy
NCT03507725
Evaluation of Functional Magnetic Resonance Imaging (fMRI) in Patients Who Speak Two Languages Fluently
NCT03496181
Neurocognitive and Neuroimaging Outcomes in Older Patients With Multiple Myeloma Treated With Autologous Stem Cell Transplantation
NCT03508765
Study of the PD-L1 Inhibitor Atezolizumab With or Without Low-dose, Local Radiation in Patients With Relapsed or Refractory Advanced Stage Follicular Lymphoma
NCT03465891
Improving Planned Surgical Case Duration Accuracy by Leveraging the EHR and Predictive Modeling
NCT03471377
Easing Psychosocial Burden for Informal Caregivers
NCT03454295
Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation
NCT03434730
Evaluating Immune Therapy, Durvalumab (MEDI4736) With Tremelimumab for Metastatic, Non-transitional Cell Carcinoma of the Urinary Tract
NCT03430895
Use of Epidurals Intraoperatively for Patients Undergoing Pancreas Resection
NCT03434678
A Study Assessing Circulation Around Surgical Incisions at the Time of Laparotomy Closure
NCT03408366
Blind Gastric Tube Placement: Incidence of Malposition Confirmed by Ultrasonography
NCT03430908
Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma
NCT03399552
Development Of A Blood Test To Improve The Performance Of Breast Cancer Screening
NCT03372902
Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?
NCT03269994
A Study of Debio 1347 Plus Fulvestrant in Patients With Metastatic Breast Cancer
NCT03344536
Using a Novel Functional MRI Technique to Evaluate for Neurotoxicity
NCT03342586
Long-Term Quality of Life in Patients With Metastatic Melanoma Treated With Checkpoint Inhibitors
NCT03326973
AZD5363 in Patients With Advanced Solid Tumors Harboring AKT Mutations
NCT03310541
Pevonedistat Alone and in Combination With Chemotherapy in Patients With Mesothelioma
NCT03319537
The Study of Bendamustine, Rituximab, Ibrutinib, and Venetoclax in Relapsed, Refractory Mantle Cell Lymphoma
NCT03295240
A Study to Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus Lanreotide
NCT03289741
Yoga for Symptoms of Nerve Damage Caused by Chemotherapy
NCT03292328
A Clinical Trial of Endoscopic Surgery Followed by Chemotherapy and Proton Radiation for the Treatment of Tumors in the Sinus and Nasal Passages
NCT03274414
Prospective Evaluation of Taste Function In Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation
NCT03276481
Decision Making and Psychological Outcomes in Low-Risk Papillary Thyroid Cancer
NCT03300284
A Study of Carboplatin and Paclitaxel Chemotherapy With Nivolumab With or Without Ipilimumab in Patients With Ovarian Cancer
NCT03245892
A Study of Nivolumab in Selected Uterine Cancer Patients
NCT03241745
Proton Re-Irradiation for Recurrent Head and Neck Cancer
NCT03217188
Acupuncture for Symptoms of Nerve Damage
NCT03183037
Ambulatory Cancer Care Electronic Symptom Self-Reporting for Surgical Patients
NCT03178045
Study of Nivolumab Plus Ipilimumab in Patients With Salivary Gland Cancer
NCT03172624
PU-H71 With Nab-paclitaxel (Abraxane) in Metastatic Breast Cancer
NCT03166085
A Custom-Designed MR Coil for Spine Radiotherapy Treatment Planning
NCT03170531
Pfizer PF-06688992 in Patients With Stage III or Stage IV Melanoma
NCT03159117
Fungal Prophylaxis With Isavuconazole for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT)
NCT03149055
Immunotherapy and Stereotactic Body Radiotherapy (SBRT) for Metastatic Anaplastic Thyroid Cancer
NCT03122496
A Clinical Trial of Durvalumab and Tremelimumab, Administered With Radiation Therapy or Ablation in Patients With Colorectal Cancer
NCT03122509
A Study of MEK162 (Binimetinib) in Combination With Pexidartinib in Patients With Advanced Gastrointestinal Stromal Tumor (GIST)
NCT03158103
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 461 |
| Phase 2 | 640 |
| Phase 3 | 67 |
| Phase 4 | 8 |
Therapeutic Areas
What is open in the Memorial Sloan Kettering Cancer Center pipeline
327 recruiting of 1,884 indexed (17% open); 1,104 completed (59%).
Phase mix: 75 late (III/IV) vs 1,101 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (98 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.